| WAVERLEY PHARMA INC. |
| Kanada |
| Gesundheit |
| CA94357L1058 / A2QALA |
| 5GZ (Frankfurt) |
| FRA:5GZ, ETR:5GZ, 5GZ:GR |
| - |
| https://www.waverleypharm.. |
|
Waverley Pharma Inc. is a biotechnology firm specializing in the research, development, and commercialization of generic oncology and other pharmaceutical products. The company aims to provide effective and affordable medication options primarily foc..
>Volltext.. |
| 0.5 Mio. EUR |
| 2.43 Mio. EUR |
| 0.94 Mio. EUR |
| -0.06 Mio. EUR |
| -0.23 Mio. EUR |
| - |
| 2 Mio. EUR |
| 0.04 Mio. EUR |
| -0.29 Mio. EUR |
| 0.02 |
| 1850.81% |
| 84.72% |
| - |
| - |
| - |
| - |
| WAVERLEY PHARMA |
| 04.04.26 |
|